As the prevalence of respiratory ailments continues to increase, people are turning to interventions to help them manage their symptoms. One such intervention that has gained prominence, particularly in the United States, is the use of steroid inhalers to reduce inflammation and help reduce asthma symptoms. These steroid inhalers are often covered by Medicare, the federal health insurance program administered by the Centers for Medicare and Medicaid Services (CMS).

The most common form of Medicare coverage for asthma is Part B Medicare, which covers certain types of inpatient and outpatient care. A wide range of services, such as doctor’s visits, lab tests, medical equipment, and medications, are covered. In terms of asthma, Part B Medicare covers inhalers used to prevent and treat asthma symptoms. Steroid inhalers, also known as bronchodilators, are commonly prescribed by physicians to help people with asthma manage their symptoms and reduce inflammation in the airways.

The positive benefits of steroid inhalers are numerous. Asthmatics are able to manage their symptoms with the help of these inhalers, while reducing the frequency of asthma attacks. In addition, they have been shown to improve quality of life by reducing fatigue, improving sleep, and increasing one